Access cutting-edge painful diabetic neuropathy treatment through this clinical trial at a research site in Lebanon. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lebanon location
Preparing your pre-screening questions…
Access painful diabetic neuropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related painful diabetic neuropathy treatment provided free
Check if you qualify for this painful diabetic neuropathy clinical trial in Lebanon, NH
No-Cost Study Care
Local to Lebanon
Convenient for NH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Diabetes affects more than 30 million people in the United States and is a leading cause of morbidity. Over 25% diabetics also suffer from debilitating painful diabetic neuropathy in the lower legs and feet. This pain can be severe, difficult to control, and have a significant negative impact on quality of life. Opioid medications have historically been a mainstay of treatment for this pain, despite the risks. As the death toll from the U.S. opioid epidemic continues to rise, the need for quality alternative non-opioid medications to treat pain becomes more urgent. One of these potential medications is Low-Dose Naltrexone (LDN). This drug is reported to work by enhancing the body's natural pain relieving mechanisms and decreases inflammation by targeting specific cells called microglia which have been shown to influence chronic pain. LDN has been shown to be a safe medication with minimal side effects. Its efficacy has been demonstrated in other painful conditions but has never been fully studied for treating painful diabetic neuropathy. The goal of this randomized, placebo-controlled trial is to determine if LDN is effective for treating the pain caused by diabetic neuropathy. LDN's mechanism of action is well suited to treating painful diabetic neuropathy, and LDN shows significant promise as a safe, non-opioid alternative that can decrease pain and improve quality of life for those suffering from this painful condition.
Sponsor: Dartmouth-Hitchcock Medical Center
Yes, this clinical trial (NCT04678895) has an active research site in Lebanon, NH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for painful diabetic neuropathy treatment options in Lebanon, NH, this clinical trial (NCT04678895) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lebanon research site is actively enrolling participants for this clinical trial. You'll receive care from experienced painful diabetic neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all painful diabetic neuropathy clinical trials near you to find additional studies recruiting in your area.
See all neuropathy clinical trials recruiting in Lebanon — not just this study.
Browse Neuropathy Trials in Lebanon →